ResearchVeterans' Decision Making for Prostate Cancer Germline Testing After Informed Consent With Their Oncologist: A Mixed-Methods Study
ResearchShared Decision-Making Needs, Barriers, and Facilitators of Patients With Newly Diagnosed Advanced Cancer in the Hospital: A Multi-Level, Mixed-Methods Study
ResearchAccuracy, Readability, and Quality of Websites About Metastatic Renal Cell Carcinoma Treatment
ResearchGermline Testing for Veterans With Advanced Prostate Cancer: Concerns About Service-Connected Benefits
ResearchPatients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate Cancer
ResearchClinical Characteristics, Racial Inequities, and Outcomes in Patients With Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
ResearchImplementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer
ResearchIntermittent Hormonal Therapy in Biochemical Recurrence of Prostate Cancer Is Worth Considering Because of Mitigation of Cardiovascular Events and Reduction of Other Effects
ResearchSystemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
ResearchCOVID-19 Severity and Cardiovascular Outcomes in SARS-CoV-2-Infected Patients With Cancer and Cardiovascular Disease
ResearchImpact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin
ResearchSomatic Alterations Associated With Response to Enfortumab Vedotin in Patients With Advanced Urothelial Cancer
ResearchSingle-Dose Lu-PSMA-617 Followed by Maintenance Pembrolizumab in Patients With Metastatic Castration-Resistant Prostate Cancer: An Open-Label, Dose-Expansion, Phase 1 Trial
ResearchDemographics, Outcomes, and Risk Factors for Patients With Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study